Sir:
The accomplishment of an efficient method for obtaining the previously unknown 1,3,2"',6"'-tetra-N-acetylparomomycin (1) and the subsequent preparation of the pseudotrisaccharide 5-0-[3-0-(2,6-diami no-2,6-dideoxy-f-L-idopyranosyl)-/3-L-ribo-furanosyl]-2-deoxystreptamine(5), as described in the preceding papery, by nitrous acid deamination, suggested a route for providing a useful intermediate for the synthesis of novel aminoglycoside antibiotics related to paromomycin and neomycin and modified in the glucosamine moiety. In order to investigate the structure-activity requirements for the glycoside unit linked to the C-4 hydroxy group of 2-deoxvstreptamine and to obtain new analogues, we have undertaken the preparation of a selectively protected derivative of the pseudotrisaccharide 5 derived from paromomycin and lacking the glucosamine moiety.
Reaction of 1,3,2"',6"'-tetra-N-acetylparomomycin (1)1) with benzyloxycarbonyl chloride gave the corresponding 2'-N-benzyloxycarbonyl derivative (2) Nitrous acid deamination of 4 gave a mixture containing two main products which were separated by column chromatography on silica gel. The less polar component was identified as 5-(acetoxymethyl)-2-furaldehyde after comparison with an authentic sample prepared by deamination of 1,3,4,6-tetra-O-acetyl-2-amino-2-deoxy-a-n-glucopyranose hydrochloride> . The major product (m.p. 157-160°C; [a]D +17', CHC13), obtained in an overall yield of 50%, was identified as
Since no analogues of paromomycin have been found to contain the 6-amino-6-deoxy-a-D-glycopyranosyl unit linked to the 4-position of the 2-deoxystreptamine ring, it seemed worthwhile to prepare such analogues from compound 6. For the glycosidation of compound 6, we applied the LEMIEUx-NAGABHUSHAN reaction which has been reported to give a-glycosides3> and which had been successfully used for the synthesis of kanamycin analogues".
As an example of the general procedure, the synthesis of 9 is reported. [a]D +29°, H20) in a 2% overall yield and was identified on the basis of its H N.M.R. spectrum as the 2'-manno-analog of 9, resulting from the non-stereoselective sodium borohydride reduction of the 2'-ketone10).
In order to investigate the effect of inversion of stereochemistry at the 4'-position on biological activity, the galacto-analog of 9 was also synthesized by the above-described procedure. sensitive organisms, and a two-fold increased activity against some resistant strains of gramnegative bacteria, while the manno-and galactoanalogs show a weak antibacterial activity, as shown in Table 1 . 
